Potentiation of the cytotoxic action of melphalan and "activated" cyclophosphamide against cultured tumor cells by centrophenoxine
- PMID: 319221
Potentiation of the cytotoxic action of melphalan and "activated" cyclophosphamide against cultured tumor cells by centrophenoxine
Abstract
Centrophenoxine, without antitumor activity itself, enhanced the cytotoxic action of melphalan and "activated" cyclophosphamide against mouse P388 lymphoma and rat W256 carcinosarcoma cells growing in static suspension culture. The concentration of alkylating agent required for 99% cell-kill was approximately halved when centrophenoxine was also present during exposure to the antitumor drug. Maximum potentiation by centrophenoxine of the cytotoxic action of melphalan occurred when cells were exposed to the two agents simultaneously; little or no potentiation was observed when cells were exposed to centrophenoxine before or after exposure to the alkylating agent.
Similar articles
-
Potentiation of antitumor drug action by centrophenoxine: specificity.J Pharmacol Exp Ther. 1977 May;201(2):518-26. J Pharmacol Exp Ther. 1977. PMID: 323465
-
Cytotoxic activity of alkylating agents in the presence of centrophenoxine and its hydrolysis products.J Pharmacol Exp Ther. 1977 Dec;203(3):630-9. J Pharmacol Exp Ther. 1977. PMID: 336870 No abstract available.
-
Cytotoxic activity of mechlorethamine and melphalan against cultured tumor cells: potentiation by caffeine.J Pharmacol Exp Ther. 1978 Aug;206(2):388-97. J Pharmacol Exp Ther. 1978. PMID: 682121 No abstract available.
-
[Diurnal variations in the response of cells to factors altering mitotic activity].Usp Sovrem Biol. 1978 Sep-Oct;86(2):216-26. Usp Sovrem Biol. 1978. PMID: 364862 Review. Russian. No abstract available.
-
Cyclophosphamide and melphalan as immunopotentiating agents in cancer therapy.Med Oncol Tumor Pharmacother. 1989;6(1):77-85. doi: 10.1007/BF02985227. Med Oncol Tumor Pharmacother. 1989. PMID: 2657252 Review.
Cited by
-
Inhibition of diacylglycerol:CDPcholine cholinephosphotransferase activity by dimethylaminoethyl p-chlorophenoxyacetate.Lipids. 1978 Feb;13(2):161-4. doi: 10.1007/BF02533260. Lipids. 1978. PMID: 204847
-
Increase in the effectiveness of melphalan therapy with progression of MOPC-315 plasmacytoma tumor growth.Cancer Immunol Immunother. 1983;15(2):101-7. doi: 10.1007/BF00199699. Cancer Immunol Immunother. 1983. PMID: 6553510 Free PMC article.